Circulating levels of IGFBP-2 are suppressed in obese individuals, an effect which is more linked to visceral adiposity, suggesting a novel role of IGFBP-2 in obesity prevention [21,22,23]. This evidence concerns the gene IGFBP2 and obesity disorder.